Hannah Pugh

@hannahpugh.bsky.social

Welsh postdoc @ The Crick with Dr. Eachan Johnson. TB and ESKAPE pathogen research. Interested in high-throughput, genomics, and chem biol. PhD from University of Birmingham with Prof. Jess Blair. Views my own. (she/her)

E. coli ST131 is becoming carbapenem resistant. I suspect as CTX-M moves onto the chromosome and the F plasmid is lost facilitating acquisition of carbapenemase plasmids. No good can come of this

The Lancet Microbe@lancetmicrobe.bsky.social · 3mo ago

New research article Emergence of carbapenemase-producing #Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey) www.thelancet.com/journals/lan... #IDSky #ClinMicro #AMR #Ecoli #OpenAccess #OA

New Review 👇 The molecular evolution of vertebrate organs: www.nature.com/articles/s41... Margarida Cardoso-Moreira discusses rates of evolution of organs and cell types, molecular mechanisms of organ evolution and how complex traits contributed to the diversification of vertebrates.

The molecular evolution of vertebrate organs - Nature Ecology & Evolution

This Review discusses recent advances in the molecular evolution of vertebrate organs, including rates of evolution of organs and cell types, molecular mechanisms of organ evolution and how complex tr...

nature.com

We're hiring a Postdoctoral Fellow! How does Mycobacterium tuberculosis survive drug treatment? You'll use molecular genetics and single-cell approaches to investigate how gene expression variability drives drug-tolerant subpopulations. Full details and application instructions below.

Bild

🔥 Open postdoc position in human inflammation-driven control of infection! 🔥 Join me at the University of Geneva, Switzerland this summer as I’m moving my Wellcome-funded research activity to the Department of Microbiology and Molecular Medicine! (1/5) Please share!